Intraoperative Cryoanalgesia for Extended Pain Management Following Thoracotomy

NCT ID: NCT03538340

Last Updated: 2021-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

138 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-01

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ICE Study study will compare standard therapy (thoracic epidural) versus a novel approach (Cryoanalgesia combined with thoracic epidural) in subjects undergoing unilateral thoracotomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ICE Study is a single institution pilot study designed to compare standard therapy (i.e., thoracic epidural) versus a novel approach (i.e., Cryoanalgesia combined with thoracic epidural) to address the need for better management of acute and long-term pain in the general thoracic surgery patient population. The study's primary objective will be to demonstrate if the new intraoperative pain management approach \[i.e., intercostal Cryoanalgesia in conjunction with thoracic epidural\] provides superior short-term and long-term analgesia efficacy in patients undergoing unilateral thoracotomy as compared to the current institutional standard of care (i.e., thoracic epidural). Patients will be randomized in a 1:1 design.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Post-thoracotomy Pain Acute Post-thoracotomy Pain Post-thoracotomy Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Control Arm: Surgery without intercostal Cryoanalgesia + Standard of Care (thoracic epidural)

Group Type ACTIVE_COMPARATOR

Thoracic Epidural

Intervention Type PROCEDURE

The control arm will receive standard of care pain management which includes a Thoracic Patient Controlled Epidural

Study Arm

Study Arm: Surgery with intercostal Cryoanalgesia + Standard of Care (thoracic epidural)

Group Type EXPERIMENTAL

Thoracic Epidural

Intervention Type PROCEDURE

The control arm will receive standard of care pain management which includes a Thoracic Patient Controlled Epidural

Intercostal Cryoanalgesia

Intervention Type PROCEDURE

The study arm will receive standard of care pain management which includes a Thoracic Epidural plus Intraoperative Intercostal Cryoanalgesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracic Epidural

The control arm will receive standard of care pain management which includes a Thoracic Patient Controlled Epidural

Intervention Type PROCEDURE

Intercostal Cryoanalgesia

The study arm will receive standard of care pain management which includes a Thoracic Epidural plus Intraoperative Intercostal Cryoanalgesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing unilateral thoracotomy for non-cardiac surgery
* Age 18-85 years of age; male or female
* Acceptable surgical candidate including use of general anesthesia
* Willing and able to provide written informed consent
* Willing and able to return for scheduled follow-up visits

Exclusion Criteria

* Prior major surgery within the last 6-months
* Documented psychiatric disease
* Documented chronic pain syndrome
* Current use of prescription opioids
* Documented history of substance abuse
* Functional disability or impairment (ECOG score = 0 or 1)
* Current pregnancy
* Patients currently enrolled in another research study that could directly affect results of either study
* Physical or mental condition that would interfere with patient's self-assessment of pain
* A medical condition that in the investigator's opinion could adversely impact the patient's participation or safety, conduct of the study or interferes with the pain assessments
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AtriCure, Inc.

INDUSTRY

Sponsor Role collaborator

University of Maryland, Baltimore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joseph S. Friedberg, MD

Professor; Surgeon-in-Chief, UMMS Division of Thoracic Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph S Friedberg, MD

Role: PRINCIPAL_INVESTIGATOR

U Maryland, Baltimore

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Maryland Medical Center

Baltimore, Maryland, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Melissa Culligan, RN, MS

Role: CONTACT

410-328-6366

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Melissa Culligan, RN, MS

Role: primary

215-570-0854

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HP-00079115

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.